MARAVAI LIFESC.HLD.A -01
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Producti… Read more
Market Cap & Net Worth: MARAVAI LIFESC.HLD.A -01 (MAR)
MARAVAI LIFESC.HLD.A -01 (F:MAR) has a market capitalization of $395.97 Million (€385.76 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #13520 globally and #1417 in its home market, demonstrating a -13.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MARAVAI LIFESC.HLD.A -01's stock price €2.66 by its total outstanding shares 145022751 (145.02 Million).
MARAVAI LIFESC.HLD.A -01 Market Cap History: 2021 to 2026
MARAVAI LIFESC.HLD.A -01's market capitalization history from 2021 to 2026. Data shows change from $5.32 Billion to $395.97 Million (-39.48% CAGR).
MARAVAI LIFESC.HLD.A -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MARAVAI LIFESC.HLD.A -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MAR by Market Capitalization
Companies near MARAVAI LIFESC.HLD.A -01 in the global market cap rankings as of March 18, 2026.
Key companies related to MARAVAI LIFESC.HLD.A -01 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MARAVAI LIFESC.HLD.A -01 Historical Marketcap From 2021 to 2026
Between 2021 and today, MARAVAI LIFESC.HLD.A -01's market cap moved from $5.32 Billion to $ 395.97 Million, with a yearly change of -39.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €395.97 Million | -5.00% |
| 2025 | €416.81 Million | -44.00% |
| 2024 | €744.31 Million | -16.67% |
| 2023 | €893.17 Million | -53.88% |
| 2022 | €1.94 Billion | -63.63% |
| 2021 | €5.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MARAVAI LIFESC.HLD.A -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $395.97 Million USD |
| MoneyControl | $395.97 Million USD |
| MarketWatch | $395.97 Million USD |
| marketcap.company | $395.97 Million USD |
| Reuters | $395.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.